Case Report
The effects of L-carnitin in Budd-Chiari syndrome in a domestic cat
Aliye Sağkan Öztürk ,
Nuri Altuğ ,
Serkan İrfan Köse * ,
Oktay Hasan Öztürk

Mac Vet Rev 2016; 39 (1): 123 - 127

10.1515/macvetrev-2015-0066

Received: 30 July 2015

Received in revised form: 12 November 2015

Accepted: 17 November 2015

Available Online First: 25 November 2015

Published on: 15 March 2016

Correspondence: Serkan İrfan Köse, srknirfn@gmail.com
PDF HTML

Abstract

This paper describes a thrombosis in the vena cava caudalis of a 15 year-old cat with ascites. Trauma and eventually feline enteric corona virus infection in the cat were not detected. In the intrahepatic region, a blockage of vena cava caudalis was brought to light by ultrasonographic imaging. An aspirate of abdominal fl uid revealed modified transudate. Liver enzyme levels were increased in the serum sample of the cat. The levels of total oxidant status (TOS) and total antioxidant status (TAS) were elevated in the peritoneal fluid. Liver protection diet with L-carnitine, diuretic therapy and antimicrobial drugs were administrated for treatment of the cat. During the continuous treatment, the amount of abdominal fluid decreased, but never completely absorbed. L-carnitine was administered to the cat during the time of treatment, and subsequently the levels of liver enzymes decreased. However, the cat died because of recurrent ascites and persistent thrombosis. In conclusion, ultrasonographic examination was very reliable, non-invasive and highly useful diagnostic method for BCS and L-carnitine has crucial effects on the quality of life, energy metabolism and liver enzyme levels. However, the blockage of the vena cava caudalis could not completely respond to medical treatment and thrombosis should be eliminated by surgical intervention.

Keywords: Budd-Chiari syndrome, cat, L-carnitine, peritoneal fluid

References

1. Simpson, I.W. (1982). Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterol. 82, 171-178.

2. Stanley, P. (1989). Budd-Chiari syndrome. Radiol. 170, 625-627. http://dx.doi.org/10.1148/radiology.170.3.2644657 PMid:2644657

3. Nakamura T., Nakamura S., Aikawa T., Suziki, O., Onodera, A., Karoji, N. (1968). Obstruction of the inferior vena cava in the hepatic portion and the hepatic veins. Angiol. 19(8): 479-500. http://dx.doi.org/10.1177/000331976801900805

4. Amesur, N.B., Zajko, A.B. (2006). Interventional radiology in liver transplantation. Liver Transpl Surg. 12, 330-351. http://dx.doi.org/10.1002/lt.20731 PMid:16498660

5. Zhang, X., Qing-Le, L. (2007). Etiology, treatment, and classification of Budd-Chiari syndrome. Chin Med J. 120, 159-161. http://dx.doi.org/10.3901/JME.2007.04.159

6. Durgut, R., Ataseven, V.S., Sagkan-Ozturk, A., Ozturk, O.H. (2013). Evaluation of total oxidative stress and total antioxidant status in cows with natural bovine herpesvirus-1 infection. J Anim Sci. 91, 1–5. http://dx.doi.org/10.2527/jas.2012-5516 PMid:23798525

7. Erel, O. (2004). A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 37, 112-119. http://dx.doi.org/10.1016/j.clinbiochem.2003.10.014 PMid:14725941

8. Erel, O. (2005). A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 38, 1103-1111. http://dx.doi.org/10.1016/j.clinbiochem.2005.08.008 PMid:16214125

9. Schrope, D.S. (2010). Hepatic vein stenosis (Budd-Chiari syndrome) as a cause of ascites in a cat. J Vet Cardiol. 12, 197-202. http://dx.doi.org/10.1016/j.jvc.2010.05.002 PMid:21078565

10. Okuda, K., Kage, M., Shrestha, S.M. (1998). Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 28, 1191-1198. http://dx.doi.org/10.1002/hep.510280505 PMid:9794901

11. Okuda, K. (2001). Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol. 16, 1179-1183.
http://dx.doi.org/10.1046/j.1440-1746.2001.02577.x PMid:11903732

12. Takayasu, K., Muramatsu, Y., Moriyama, N., Wakao, F., Makuuchi, M., Takayama, T., Kosuge, T., Okazaki, N., Yamada, R. (1994). Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma: a report of four cases. Am J Gastroenterol. 88, 249-253.

13. Horoz, M., Bolukbas, C., Bolukbas, F.F., Aslan, M., Koylu, A.O., Selek, S., Erel, O. (2006). Oxidative stres in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis. 6, 114. http://dx.doi.org/10.1186/1471-2334-6-114 PMid:16842626 PMCid:PMC1543638

14. Karaagac, L., Koruk, S.T., Koruk, I., Aksoy, N. (2011). Decreasing oxidative stress in response to treatment in patients with brucellosis: could it be used to monitor treatment. Int J Infect Dis. 15(5): 346-349. http://dx.doi.org/10.1016/j.ijid.2011.01.009 PMid:21376649

15. Karsen, H., Sunnetcioglu, M., Ceylan, R.M. (2011). Evaluation of oxidative status in patients with Fasciola hepatica infection. Afr Health Sci. 11(1): 14-18. http://dx.doi.org/10.4314/ahs.v11i3.70064

16. Maden, M., Ozturk, S.A., Bulbul, A., Avci, G.,Yazar, E. (2012). Acute phase proteins, oxidative stress and enzyme activities of blood serum and peritoneal fluid in abomasal displacement cases. J Vet Intern Med. 26, 1470–1475. http://dx.doi.org/10.1111/j.1939-1676.2012.01018.x PMid:23113812

17. Braun, U. (2008). Clinical findings and diagnosis of thrombosis of the caudal vena cava in cattle. The Vet J. 175, 118–125. http://dx.doi.org/10.1016/j.tvjl.2006.11.013 PMid:17239635

18. Fisher, N.C., Mccafferty, I., Dolapci, M., Wali, M., Buckels, J.A.C., Olliff, S.P., Elias, E. (1999). Managing Budd-Chiari syndrome: a restrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 44, 568-574. http://dx.doi.org/10.1136/gut.44.4.568 PMid:10075967 PMCid:PMC1727471

19. Lin, X.H., Jiao, L.L., Xu, G.B., Tian, G.S. (2006). Significance of serum carnitine in patients with liver diseases. Zhonghua Gan Zang Bing ZaZhi, 14(5): 367-369.

20. Malaguarnera, M., Vacante, M., Giordano, M., Motta, M., Bertino, G., Pennisi, M., Neri, S., Malaguernera, M., Li Volti, G., Galvano, F. (2011). L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol. 17(39): 4414-4420. http://dx.doi.org/10.3748/wjg.v17.i39.4414 PMid:22110268 PMCid:PMC3218156

21. Cekin, AH., Gur, G., Turkoglu, S., Aldemir, D., Yılmaz, U., Gursoy, M., Taskoparan, M., Boyacıoğlu, S. (2013). The protective effect of L-carnitine on hepatic ischemia-reperfusion injury in rats. Turk J Gastroenterol. 24 (1): 51-56. PMid:23794344

Copyright

© 2015 Ozturk A.S. This is an open-access article publishedunder the terms of the Creative Commons Attribution License whichpermits unrestricted use, distribution, and reproduction in any medium,provided the original author and source are credited.

Conflict of Interest Statement

The authors declared that they have no potential conflict of interest with respect to the authorship and/or publication of this article.

Citation Information

Macedonian Veterinary Review. Volume 39, Issue 1, Pages 123-127, p-ISSN 1409-7621, e-ISSN 1857-7415, DOI: 10.1515/macvetrev-2015-0066, 2016

The all content of the Macedonian Veterinary Review, except where otherwise noted, is licensed under a Creative Commons Attribution License.